Healthcare provider profile · identity verified

Christopher William Coppeans, MD

Family Practice · FEDERAL WAY, WA · NPI 1194922526

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	535	166
Amlodipine Besylate	Amlodipine Besylate	308	102
Lisinopril	Lisinopril	299	89
Losartan Potassium	Losartan Potassium	273	86
Omeprazole	Omeprazole	257	70
Gabapentin	Gabapentin	221	62
Levothyroxine Sodium	Levothyroxine Sodium	212	55
Hydrochlorothiazide	Hydrochlorothiazide	190	56
Metformin Hcl	Metformin Hcl	147	42
Albuterol Sulfate Hfa	Albuterol Sulfate	125	52
Trazodone Hcl	Trazodone Hcl	125	37
Metformin Hcl Er	Metformin Hcl	120	38
Simvastatin	Simvastatin	119	35
Metoprolol Succinate	Metoprolol Succinate	114	44
Fluticasone Propionate	Fluticasone Propionate	108	32
Trulicity	Dulaglutide	101	24
Bupropion Xl	Bupropion Hcl	92	19
Pantoprazole Sodium	Pantoprazole Sodium	92	24
Tamsulosin Hcl	Tamsulosin Hcl	90	29
Famotidine	Famotidine	86	25
Sertraline Hcl	Sertraline Hcl	74	22
Oxycodone Hcl	Oxycodone Hcl	72	12
Alendronate Sodium	Alendronate Sodium	70	15
Ozempic	Semaglutide	70	11
Montelukast Sodium	Montelukast Sodium	69	15
Allopurinol	Allopurinol	64	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	18
Fluoxetine Hcl	Fluoxetine Hcl	60	11
Furosemide	Furosemide	60	19
Meloxicam	Meloxicam	60	19
Tizanidine Hcl	Tizanidine Hcl	59	19
Pregabalin	Pregabalin	57	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	57	18
Citalopram Hbr	Citalopram Hydrobromide	53	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	16
Clopidogrel	Clopidogrel Bisulfate	49	11
Atenolol	Atenolol	48	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	suppressed
Methocarbamol	Methocarbamol	44	11
Triamcinolone Acetonide	Triamcinolone Acetonide	42	18
Glipizide	Glipizide	41	12
Valacyclovir	Valacyclovir Hcl	41	13
Duloxetine Hcl	Duloxetine Hcl	37	11
Estradiol	Estradiol	37	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Finasteride	Finasteride	36	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	35	suppressed
Ibuprofen	Ibuprofen	35	11
Baclofen	Baclofen	34	11
Chlorthalidone	Chlorthalidone	34	11
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	12
Xarelto	Rivaroxaban	33	12
Ondansetron Odt	Ondansetron	31	17
Tramadol Hcl	Tramadol Hcl	31	suppressed
Carvedilol	Carvedilol	30	suppressed
Irbesartan	Irbesartan	30	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Potassium Chloride	Potassium Chloride	29	13
Spironolactone	Spironolactone	28	12
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Topiramate	Topiramate	27	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Mounjaro	Tirzepatide	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Naproxen	Naproxen	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Dulera	Mometasone/Formoterol	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Prednisone	Prednisone	20	12
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Ibu	Ibuprofen	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Mupirocin	Mupirocin	18	14
Ursodiol	Ursodiol	18	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Eliquis	Apixaban	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Verapamil Er Pm	Verapamil Hcl	14	suppressed
Verapamil Hcl	Verapamil Hcl	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	11	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error